Yamamoto-Hino Miki, Muraoka Masatoshi, Kondo Shu, Ueda Ryu, Okano Hideyuki, Goto Satoshi
Department of Life Science, Rikkyo University, Tokyo 171-8501, Japan;
Stem Cell Project Group, Tokyo Metropolitan Institute of Medical Science, Tokyo 156-8506, Japan;
Proc Natl Acad Sci U S A. 2015 May 5;112(18):5809-14. doi: 10.1073/pnas.1424514112. Epub 2015 Apr 21.
The innate immune system is the first line of defense encountered by invading pathogens. Delayed and/or inadequate innate immune responses can result in failure to combat pathogens, whereas excessive and/or inappropriate responses cause runaway inflammation. Therefore, immune responses are tightly regulated from initiation to resolution and are repressed during the steady state. It is well known that glycans presented on pathogens play important roles in pathogen recognition and the interactions between host molecules and microbes; however, the function of glycans of host organisms in innate immune responses is less well known. Here, we show that innate immune quiescence and strength of the immune response are controlled by host glycosylation involving a novel UDP-galactose transporter called Senju. In senju mutants, reduced expression of galactose-containing glycans resulted in hyperactivation of the Toll signaling pathway in the absence of immune challenges. Genetic epistasis and biochemical analyses revealed that Senju regulates the Toll signaling pathway at a step that converts Toll ligand Spatzle to its active form. Interestingly, Toll activation in immune-challenged wild type (WT) flies reduced the expression of galactose-containing glycans. Suppression of the degalactosylation by senju overexpression resulted in reduced induction of Toll-dependent expression of an antimicrobial peptide, Drosomycin, and increased susceptibility to infection with Gram-positive bacteria. These data suggest that Senju-mediated galactosylation suppresses undesirable Toll signaling activation during the steady state; however, Toll activation in response to infection leads to degalactosylation, which raises the immune response to an adequate level and contributes to the prompt elimination of pathogens.
先天性免疫系统是抵御入侵病原体的第一道防线。先天性免疫反应的延迟和/或不足会导致无法对抗病原体,而过度和/或不适当的反应则会引发失控的炎症。因此,免疫反应从启动到消退都受到严格调控,在稳态期间受到抑制。众所周知,病原体上呈现的聚糖在病原体识别以及宿主分子与微生物之间的相互作用中发挥重要作用;然而,宿主生物体聚糖在先天性免疫反应中的功能却鲜为人知。在此,我们表明先天性免疫的静止状态和免疫反应的强度由宿主糖基化控制,这涉及一种名为“千手”的新型尿苷二磷酸半乳糖转运蛋白。在千手突变体中,含半乳糖聚糖的表达减少导致在没有免疫挑战的情况下Toll信号通路过度激活。遗传上位性和生化分析表明,千手在将Toll配体Spatzle转化为其活性形式的步骤中调节Toll信号通路。有趣的是,在受到免疫挑战的野生型(WT)果蝇中,Toll激活会降低含半乳糖聚糖的表达。通过过表达千手来抑制去半乳糖基化会导致抗菌肽Drosomycin的Toll依赖性表达诱导减少,并增加对革兰氏阳性菌感染的易感性。这些数据表明,千手介导的半乳糖基化在稳态期间抑制了不良的Toll信号激活;然而,对感染的Toll激活会导致去半乳糖基化,从而将免疫反应提高到适当水平,并有助于迅速清除病原体。